GSK Raises Guidance After Sales, Earnings Growth

The Wall Street JournalWednesday, October 29, 2025 at 8:08:00 AM
GSK Raises Guidance After Sales, Earnings Growth
GSK has raised its sales growth guidance for 2025, now projecting an increase of 6% to 7% when excluding currency fluctuations, a significant improvement from the previous estimate of 3% to 5%. This positive adjustment reflects the company's strong performance and confidence in its future, which is crucial for investors and stakeholders as it indicates a robust pipeline and market demand for its products.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Trump says he will cut fentanyl tariff on Chinese goods and expects ‘great deal’ with Xi – business live
PositiveFinancial Markets
In a move that could reshape trade relations, Trump announced plans to cut the fentanyl tariff on Chinese goods, expressing optimism for a 'great deal' with Xi. This news comes as Asian stock markets rally on the anticipation of a trade deal and a potential US interest rate cut. Additionally, GSK's CEO Emma Walmsley is stepping down after eight years, but not before the company raised its 2025 sales and profit forecasts, showcasing strong growth in key areas. This combination of trade optimism and corporate success highlights a potentially positive shift in the economic landscape.
Telenor stock slides after small earnings miss, tightened guidance
NegativeFinancial Markets
Telenor's stock has taken a hit following a slight miss in earnings and a tightening of its financial guidance. This news is significant as it reflects the company's current challenges in meeting market expectations, which could impact investor confidence and future performance.
GSK cancer, HIV drug sales lift 2025 outlook in boost to shares
PositiveFinancial Markets
GSK has reported a significant increase in sales of its cancer and HIV drugs, leading to an optimistic outlook for 2025 and a boost in its share prices. This positive trend not only reflects the company's strong performance in the pharmaceutical market but also highlights the growing demand for effective treatments in these critical areas. Investors are encouraged by the potential for continued growth, making GSK a company to watch in the coming years.
BIC lowers outlook after flat Q3 sales, shares drop
NegativeFinancial Markets
BIC has lowered its outlook following stagnant sales in the third quarter, leading to a drop in its shares. This news is significant as it reflects the company's struggles in a competitive market, raising concerns among investors about its future performance and growth potential.
Mercedes-Benz Confirms Guidance After Tariffs, Chinese Weakness Weigh on Earnings
NeutralFinancial Markets
Mercedes-Benz has confirmed its financial guidance despite facing challenges from U.S. tariffs and a tough market in China. The company announced it will continue with a share buyback program, indicating confidence in its long-term strategy. This move is significant as it reflects the brand's resilience in navigating external pressures while maintaining shareholder value.
Equinor reports earnings miss, cash flow beat in Q3; shares slip
NegativeFinancial Markets
Equinor's recent earnings report revealed a miss in expected earnings for the third quarter, although the company managed to exceed cash flow expectations. This mixed performance led to a decline in shares, highlighting the challenges the company faces in a fluctuating market. Investors are keenly watching how Equinor navigates these hurdles, as the energy sector continues to experience volatility.
European shares flat; earnings, Fed’s rate decision in focus
NeutralFinancial Markets
European shares are showing little movement as investors keep a close eye on upcoming earnings reports and the Federal Reserve's decision on interest rates. This situation is significant because it reflects the cautious sentiment in the market, with traders weighing the potential impacts of economic indicators on future investments.
Adidas sales decline in North America as Yeezy impact and tariffs bite
NegativeFinancial Markets
Adidas is facing a significant sales decline in North America, largely attributed to the impact of the Yeezy brand's discontinuation and the ongoing effects of tariffs. This downturn is concerning for the company as it navigates a challenging market landscape, highlighting the importance of adapting to consumer preferences and external economic factors. The situation underscores the need for strategic adjustments to regain market traction.
Latest from Financial Markets
Next continues to profit after M&S cyber-attack
PositiveFinancial Markets
Next is on track to report a pre-tax profit exceeding £1.1 billion by the end of January 2026, despite the recent cyber-attack on M&S. This shows the resilience of Next's business model and its ability to thrive even in challenging circumstances, which is encouraging for investors and the retail sector as a whole.
Reeves vows to 'defy' gloomy economic forecasts
PositiveFinancial Markets
Chancellor Reeves is taking a bold stance against pessimistic economic forecasts, emphasizing that investment is key to enhancing the UK's productivity. This approach is significant as it aims to inspire confidence in the economy and encourage growth, which could lead to improved job opportunities and overall prosperity for the nation.
Norway’s Oil Fund Grows on Strong Equity Markets
PositiveFinancial Markets
Norway's sovereign-wealth fund has reported a remarkable 5.8% return in the third quarter, largely fueled by robust performance in sectors like basic materials, telecommunications, and finance. This growth is significant as it reflects the resilience of the fund amidst fluctuating market conditions, showcasing Norway's strategic investment approach and its potential to support the country's economy.
Assystem shares rise after Q3 revenue beats estimates on international growth
PositiveFinancial Markets
Assystem's shares have seen a notable increase following their Q3 revenue report, which exceeded analysts' expectations thanks to strong international growth. This positive performance highlights the company's successful expansion strategies and positions them favorably in the market, making it an exciting time for investors and stakeholders alike.
Nvidia nears historic $5 trillion valuation in fresh AI-fueled rally
PositiveFinancial Markets
Nvidia is on the brink of achieving a remarkable $5 trillion valuation, driven by a surge in interest and investment in artificial intelligence. This milestone is significant not only for Nvidia but also for the tech industry as a whole, highlighting the growing importance of AI technologies in shaping the future of business and innovation.
Vetoquinol shares fall as Q3 revenue misses estimates due to manufacturing issues
NegativeFinancial Markets
Vetoquinol's shares have taken a hit as the company's Q3 revenue fell short of expectations, primarily due to manufacturing issues. This decline is significant as it reflects operational challenges that could impact future growth and investor confidence. Stakeholders will be closely monitoring how Vetoquinol addresses these manufacturing hurdles to regain market trust.